Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

Alternations of fecal microbes and lung tissue microbes in Lung Cancer patients is more consistent than that of sputum

Alternations of fecal microbes and lung tissue microbes in Lung Cancer patients is more Identical than that of sputum

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Alteration of the gut microbiota in patients with lung cancer accompanied by chronic obstructive pulmonary diseases

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

[Analysis of gut microbiome in patients with lung adenocarcinoma and lung squamous cell carcinoma]

P1.01-44 the Role of Microbiota on the Development of Non-Small-Cell Lung Cancer

Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer

The Composition Alteration of Respiratory Microbiota in Lung Cancer

The Characterization of Lung Microbiome in Sputum of Lung Cancer Patients with Different Clinicopathology

Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer

Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study

Lung microbiome alterations in NSCLC patients

The Microbiome of Lower Respiratory Tract and Tumor Tissue in Lung Cancer Manifested As Radiological Ground-Glass Opacity

Difference Of Lower Airway Microbiome In Bilateral Protected Specimen Brush Between Lung Cancer Patients With Unilateral Lobar Masses And Control Subjects

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

Alterations of Gastric Mucosal Microbiota Across Different Stomach Microhabitats in a Cohort of 276 Patients with Gastric Cancer

Convergent alteration of lung tissue microbiota and tumor cells in lung cancer

Diminishing Microbiome Richness and Distinction in the Lower Respiratory Tract of Lung Cancer Patients: A Multiple Comparative Study Design with Independent Validation.

The Airway Microbiota of Non-Small-Cell Lung Cancer Patients and Its Relationship to Tumor Stage and EGFR Mutation